We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potenti... Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology. Show more
A Canadian healthcare company is already stealing the show on Thursday after the company announced that it has signed a distribution and supply agreement with Henry Schein, Inc To read the full...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.862068965517 | 1.16 | 1.21 | 1.09 | 45953 | 1.12551691 | CS |
4 | 0.05 | 4.54545454545 | 1.1 | 1.25 | 1 | 34534 | 1.1042249 | CS |
12 | -0.03 | -2.54237288136 | 1.18 | 1.34 | 1 | 25653 | 1.16807901 | CS |
26 | 0.09 | 8.49056603774 | 1.06 | 1.59 | 0.974999 | 25217 | 1.19463577 | CS |
52 | -0.34 | -22.8187919463 | 1.49 | 1.7494 | 0.974999 | 22598 | 1.29786948 | CS |
156 | -1.85 | -61.6666666667 | 3 | 3.78 | 0.974999 | 55187 | 2.51843643 | CS |
260 | -1.85 | -61.6666666667 | 3 | 3.78 | 0.974999 | 55187 | 2.51843643 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions